This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rosenberg, R. Articles by Siewert, J.-R. Search for Related Content PubMed PubMed Citation Articles by Rosenberg, R. Articles by Siewert, J.-R. Social Bookmarking                            What's this?

Prognostic Significance of Cytokeratin-20 Reverse Transcriptase Polymerase Chain Reaction in Lymph Nodes of Node-Negative Colorectal Cancer Patients

From the Chirurgische Klinik und Poliklinik and Institut für Pathologie und Pathologische Anatomie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Address reprint requests to Hjalmar Nekarda, MD, Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München, Ismaningerstr. 22, 81675 Munich, Germany; email: nekarda{at}nt1.chir.med.tu-muenchen.de

PURPOSE: Approximately 20% to 30% of patients with curatively resected, node-negative (pN0) colorectal cancer die of tumor recurrence, which can be caused by minimal residual disease. To identify patients with an increased risk of tumor recurrence and evaluate the prognostic value of cytokeratin-20 (CK-20), we detected CK-20–positive cells in histopathologically tumor-free lymph nodes (pN0) of patients with colorectal cancer.

PATIENTS AND METHODS: Two peritumoral lymph nodes each from 85 patients with completely resected (R0) colorectal cancer without lymph node metastases (pN0) by routine examination were analyzed using a CK-20–specific reverse transcriptase polymerase chain reaction (RT-PCR) and compared with CK-20–specific immunohistochemistry (IHC). The results were correlated with histopathologic findings and with survival.

RESULTS: CK-20 RT-PCR was positive in 44 patients (52%) and detected 83% of cancer-related death. Positive RT-PCR was significantly correlated with poorer overall survival (P < .009). Comparing RT-PCR with IHC, 13 patients with positive RT-PCR were identified, where the CK-20 expression was caused by tumor cell contamination located exclusively outside the lymph node capsule and had no prognostic impact. Defining these 13 patients as RT-PCR negative improved specificity of the RT-PCR assay from 57% to 75%. The 5-year overall survival of the 31 RT-PCR–positive patients was 71%, compared with 96% in the 54 negative patients (P < .001). Multivariate analysis showed expression of CK-20 mRNA to be an independent prognostic factor with a relative risk of cancer-related death of 6.1.

CONCLUSION: CK-20 RT-PCR in peritumoral histopathologic tumor-free (pN0) lymph nodes of colorectal cancer is an independent prognostic factor for overall survival. Additional CK-20 IHC improves the specificity and prognostic value of RT-PCR for cancer-related death.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. Koyanagi, A. J. Bilchik, S. Saha, R. R. Turner, D. Wiese, M. McCarter, P. Shen, L. Deacon, D. Elashoff, and D. S.B. Hoon Prognostic Relevance of Occult Nodal Micrometastases and Circulating Tumor Cells in Colorectal Cancer in a Prospective Multicenter Trial Clin. Cancer Res., November 15, 2008; 14(22): 7391 - 7396. [Abstract] [Full Text] [PDF]

				D. G. Nicastri, J. T. Doucette, T. E. Godfrey, and S. J. Hughes Is Occult Lymph Node Disease in Colorectal Cancer Patients Clinically Significant?: A Review of the Relevant Literature J. Mol. Diagn., November 1, 2007; 9(5): 563 - 571. [Abstract] [Full Text] [PDF]

				C. Codignola, F. Zorzi, A. Zaniboni, S. Mutti, A. Rizzi, E. Padolecchia, and G. B. Morandi Is there any Role for Sentinel Node Mapping in Colorectal Cancer Staging? Personal Experience and Review of the Literature Jpn. J. Clin. Oncol., November 1, 2005; 35(11): 645 - 650. [Abstract] [Full Text] [PDF]

				A. G. Dan, S. Saha, K. M. Monson, D. Wiese, E. Schochet, K. R. Barber, B. Ganatra, D. Desai, and S. Kaushal 1% Lymphazurin vs 10% Fluorescein for Sentinel Node Mapping in Colorectal Tumors Arch Surg, November 1, 2004; 139(11): 1180 - 1184. [Abstract] [Full Text] [PDF]

				A. Zaniboni and R. Labianca Adjuvant therapy for stage II colon cancer: an elephant in the living room? Ann. Onc., September 1, 2004; 15(9): 1310 - 1318. [Abstract] [Full Text] [PDF]

				L. F. Onate-Ocana, R. Montesdeoca, C. M. Lopez-Graniel, V. Aiello-Crocifoglio, R. Mondragon-Sanchez, M. Cortina-Borja, R. Herrera-Goepfert, C. Oros-Ovalle, and D. Gallardo-Rincon Identification of Patients with High-risk Lymph Node-negative Colorectal Cancer and Potential Benefit from Adjuvant Chemotherapy Jpn. J. Clin. Oncol., June 1, 2004; 34(6): 323 - 328. [Abstract] [Full Text] [PDF]

				S. Nagatani, Y. Shimada, Z. Li, J. Kaganoi, T. Kan, M. Maeda, G. Watanabe, and M. Imamura Validation of Intra-operative Detection of Paratracheal Lymph Node Metastasis Using Real-time RT-PCR Targeting Esophageal Squamous Cell Carcinoma Jpn. J. Clin. Oncol., November 1, 2003; 33(11): 549 - 555. [Abstract] [Full Text] [PDF]

				G Cserni Nodal staging of colorectal carcinomas and sentinel nodes J. Clin. Pathol., May 1, 2003; 56(5): 327 - 335. [Abstract] [Full Text] [PDF]

				D. G. Covell, A. Wallqvist, A. A. Rabow, and N. Thanki Molecular Classification of Cancer: Unsupervised Self-Organizing Map Analysis of Gene Expression Microarray Data Mol. Cancer Ther., March 1, 2003; 2(3): 317 - 332. [Abstract] [Full Text] [PDF]